维普期刊资源整合服务平台（V6.5）

78篇 您的检索式：作者名="Boffa MB"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Inhiition of plasmino- gen activati-on by lipoprotein(a) : critical domains in apolipoprotein (a) and mechanism of inhibition on fibrin and degraded fibrin sur- faces 显示文摘	Hancock MA Boffa MB Marcovina SM	2003	Biolchem Biophys Res Commun2003，278，23：	1
2	Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme显示文摘	BOFFA MB STEWART RJ	2002	J Biol Chem2002，277，：	1
3	Apolipopro- tein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipopro- tein(a)-mediated inhibition ofplasminogen activation显示文摘	Feric NT Boffa MB Johnston SM	2008	J Thromb Haemost2008，6，21：	1
4	Role of mRNA transcript stability in modulation of expression of the gene encoding thrombin activable fibrinolysis inhibitor显示文摘	Maret D Boffa MB Brien DF	2004	J Thromb Haemost2004，2，16：	1
5	A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor显示文摘	Wang W Boffa MB Bajzar L	1998	J Biol Chem1998，273，27：	1
6	The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface显示文摘	Sangrar W Gabel BR Boffa MB	1997	Biochemistry (Mosc)1997，36，10：	1
7	Lipo- protein(a) : a unique risk factor for cardiovascular dis- ease显示文摘	Anuurad E Boffa MB Koschinsky ML	2006	Clin Lab Med2006，26，4：	1
8	Subclinical vitamin K defi-ciency in hemodialysis patients显示文摘	Pilkey RM Morton AR Boffa MB		0，，：	1
9	A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor显示文摘	Wang W Boffa MB Bajzar L	1998	J Biol Chem1998，273，27：	1
10	Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/throm-bomodulin-dependent activation, thermal stability, and enzymatic properties显示文摘	Boffa MB Wang W Bajzar L	1998	J Biol Chem1998，273，4：	1
11	Characterization of the gene encoding human TAFI 显示文摘	Boffa MB Reid S Joo E	1999	Biochemistry1999，38，20：	1
12	Plasma and recombinant thrombin activatable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation,thrombin/thrombomodulindependent activation,thermal stability,and enzymatic properties显示文摘	Boffa MB Wang W Bajzar L	1998	J Biol Chem1998，273，4：	1
13	Inhibition of plasminogen activation by lipoprotein(a):critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces显示文摘	Boffa MB Marcovina SM	2003	J Biol Chem2003，278，23：	1
14	Lipoprotein (a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor显示文摘	Romagnuolo R Scipione CA Boffa MB	2015	J Bid Chem2015，290，11：	1
15	Lipoprotein(α) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models 显示文摘	Boffa MB Marcovina SM Koschlnsky ML	2004	Clin Biochem2004，37，5：	1
16	Inhibition of plasminogen activation by lipoprotein(a):critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces显示文摘	Hancock MA Boffa MB Marcovina SM	2003	J Biol chem2003，278，23：	1
17	Lipoprotein(a):a unique risk factor for cardiovascular disease显示文摘	Anuurad E Boffa MB Koschinsky ML		0，，04：	1
18	A study of the mechanism of inhibition of fibrinolysis by activated thrombin -activable fibrinolysis inhibitor显示文摘	Wang W Boffa MB Bajzar L	1998	J Biol Chem1998，273，27：	1
19	Characterization of the gene encoding human TAFI(thrombin-activable fibrinolysis inhibitor;plasma procarboxypeptidase B )显示文摘	Boffa MB Reid TS Joo E	1999	Biochemistry1999，38，20：	1
20	Association of a single nucleotide polymorphism in CPB2 encoding the thrombin -activable fibrinolysis in hibitor (TAFI) with bolld pressure显示文摘	Kochinsky ML Boffa MB	2001	Chin Genet2001，60，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示